When was dificid approval

You will receive an email when new content is published. Click Here to Manage Email Alerts. We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice slackinc.

Back to Healio. Read more about clostridioides difficile infection. FDA approves fidaxomicin for treatment of C. By Lucas Franki. Next Article: Trial of epicutaneous immunotherapy in eosinophilic esophagitis.

For additional information regarding Dificid or Clostridium difficile-associated diarrhea, please visit the Dificid web page. Lundbeck Takeda Pharmaceuticals U. Dificid fidaxomicin Profile. Profile Contact Information.

Currently Enrolling Trials Show More. General Information Dificid fidaxomicin is a narrow-spectrum macrocyclic antibiotic. Side Effects Adverse events associated with the use of Dificid may include, but are not limited to, the following: nausea vomiting abdominal pain gastrointestinal hemorrhage anemia neutropenia Mechanism of Action Fidaxomicin is bactericidal against C.

Epub Aug 19 Additional Information For additional information regarding Dificid or Clostridium difficile-associated diarrhea, please visit the Dificid web page. Ask the Experts: ClinicalTrials.